The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this approach offers a simpler way to provide GLP-1 https://saulqvbo988468.amoblog.com/glp-1-patches-a-innovative-approach-to-glucose-treatment-63020750